Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H N Lode

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Cell Proliferation|January 7, 2012
A new development of triterpene acid-containing extracts from Viscum album L. displays synergistic induction of apoptosis in acute lymphoblastic leukaemiaC I Delebinski, S Jaeger, K Kemnitz-Hassanin, et al.
Drugs of Today (Barcelona, Spain : 1998)|July 16, 2003
What to do with targeted IL-2H N Lode, R Xiang, P Perri, et al.
Journal of the National Cancer Institute|November 15, 1997
Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrowH N Lode, R Xiang, N M Varki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Suppression of human prostate carcinoma metastases in severe combined immunodeficient mice by interleukin 2 immunocytokine therapyC S Dolman, B M Mueller, H N Lode, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 1999
Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12H N Lode, R Xiang, S R Duncan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2001
IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapyU Pertl, A D Luster, N M Varki, et al.
Der Orthopade|January 28, 2014
[Incidence and duration of therapy of pathological hip findings in U2 and U3 examinations (SNiP study)]A Lange, J Lange, R Thyrian, et al.
The Journal of Clinical Investigation|June 7, 2000
Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interactionH N Lode, R Xiang, U Pertl, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2001
In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapyD Shabat, H N Lode, U Pertl, et al.
Anticancer Research|September 1, 1994
Ascorbic acid induces lipid peroxidation on neuroectodermal SK-N-LO cells with high endogenous ferritin content and loaded with MAb-ferritin immunoconjugatesH N Lode, G Bruchelt, D Zinsser, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Cell Proliferation|January 7, 2012
A new development of triterpene acid-containing extracts from Viscum album L. displays synergistic induction of apoptosis in acute lymphoblastic leukaemiaC I Delebinski, S Jaeger, K Kemnitz-Hassanin, et al.
Drugs of Today (Barcelona, Spain : 1998)|July 16, 2003
What to do with targeted IL-2H N Lode, R Xiang, P Perri, et al.
Journal of the National Cancer Institute|November 15, 1997
Targeted interleukin-2 therapy for spontaneous neuroblastoma metastases to bone marrowH N Lode, R Xiang, N M Varki, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Suppression of human prostate carcinoma metastases in severe combined immunodeficient mice by interleukin 2 immunocytokine therapyC S Dolman, B M Mueller, H N Lode, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 21, 1999
Tumor-targeted IL-2 amplifies T cell-mediated immune response induced by gene therapy with single-chain IL-12H N Lode, R Xiang, S R Duncan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2001
IFN-gamma-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapyU Pertl, A D Luster, N M Varki, et al.
Der Orthopade|January 28, 2014
[Incidence and duration of therapy of pathological hip findings in U2 and U3 examinations (SNiP study)]A Lange, J Lange, R Thyrian, et al.
The Journal of Clinical Investigation|June 7, 2000
Melanoma immunotherapy by targeted IL-2 depends on CD4(+) T-cell help mediated by CD40/CD40L interactionH N Lode, R Xiang, U Pertl, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2001
In vivo activity in a catalytic antibody-prodrug system: Antibody catalyzed etoposide prodrug activation for selective chemotherapyD Shabat, H N Lode, U Pertl, et al.
Anticancer Research|September 1, 1994
Ascorbic acid induces lipid peroxidation on neuroectodermal SK-N-LO cells with high endogenous ferritin content and loaded with MAb-ferritin immunoconjugatesH N Lode, G Bruchelt, D Zinsser, et al.
Pageof 5